Niloofar Rahmani

Array ( [id] => 7768082 [patent_doc_number] => 20120035208 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-02-09 [patent_title] => 'PYRAZOLOPYRIDINE PI3K INHIBITOR COMPOUNDS AND METHODS OF USE' [patent_app_type] => utility [patent_app_number] => 13/129091 [patent_app_country] => US [patent_app_date] => 2009-11-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24777 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0035/20120035208.pdf [firstpage_image] =>[orig_patent_app_number] => 13129091 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6569244 [patent_doc_number] => 20100234423 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-16 [patent_title] => 'TRIAZOLOTHIADIAZOLE INHIBITOR OF C-MET PROTEIN KINASE' [patent_app_type] => utility [patent_app_number] => 12/620845 [patent_app_country] => US [patent_app_date] => 2009-11-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10842 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0234/20100234423.pdf [firstpage_image] =>[orig_patent_app_number] => 12620845 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6222785 [patent_doc_number] => 20100056499 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-03-04 [patent_title] => '3-AMINO-1-ARYLPROPYL AZAINDOLES AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 12/619275 [patent_app_country] => US [patent_app_date] => 2009-11-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27389 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0056/20100056499.pdf [firstpage_image] =>[orig_patent_app_number] => 12619275 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9227550 [patent_doc_number] => 08633218 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-01-21 [patent_title] => '8-azabicyclo[3.2.1]oct-2-ene derivatives and their use as monoamine neurotransmitter re-uptake inhibitors' [patent_app_type] => utility [patent_app_number] => 13/129561 [patent_app_country] => US [patent_app_date] => 2009-11-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7792 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13129561 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6543369 [patent_doc_number] => 20100125062 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-05-20 [patent_title] => 'PYRIDINE AND PYRIMIDINE DERIVATIVES AS PHOSPHODIESTERASE 10 INHIBITORS' [patent_app_type] => utility [patent_app_number] => 12/619573 [patent_app_country] => US [patent_app_date] => 2009-11-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 82230 [patent_no_of_claims] => 112 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0125/20100125062.pdf [firstpage_image] =>[orig_patent_app_number] => 12619573 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6591923 [patent_doc_number] => 20100130540 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-05-27 [patent_title] => 'AZAQUINOLINONE DERIVATIVES AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 12/618336 [patent_app_country] => US [patent_app_date] => 2009-11-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 50335 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0130/20100130540.pdf [firstpage_image] =>[orig_patent_app_number] => 12618336 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8858642 [patent_doc_number] => 08461176 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-06-11 [patent_title] => 'Enantiomerically enriched aryloazol-2-yl cyanoethylamino compounds, method of making and method of using thereof' [patent_app_type] => utility [patent_app_number] => 12/618308 [patent_app_country] => US [patent_app_date] => 2009-11-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 114372 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12618308 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6277057 [patent_doc_number] => 20100256365 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-10-07 [patent_title] => 'COMPOUNDS AND METHODS FOR KINASE MODULATION, AND INDICATIONS THEREFOR' [patent_app_type] => utility [patent_app_number] => 12/616079 [patent_app_country] => US [patent_app_date] => 2009-11-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 203654 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0256/20100256365.pdf [firstpage_image] =>[orig_patent_app_number] => 12616079 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6307362 [patent_doc_number] => 20100069430 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-03-18 [patent_title] => 'PYRROLO[2,3-C]PYRIDINE DERIVATIVES AND PROCESSES FOR THE PREPARATION THEREOF' [patent_app_type] => utility [patent_app_number] => 12/613763 [patent_app_country] => US [patent_app_date] => 2009-11-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 112365 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0069/20100069430.pdf [firstpage_image] =>[orig_patent_app_number] => 12613763 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6321350 [patent_doc_number] => 20100113503 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-05-06 [patent_title] => 'CYCLOALKANE[B]AZAINDOLE ANTAGONISTS OF PROSTAGLANDIN D2 RECEPTORS' [patent_app_type] => utility [patent_app_number] => 12/613424 [patent_app_country] => US [patent_app_date] => 2009-11-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12041 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0113/20100113503.pdf [firstpage_image] =>[orig_patent_app_number] => 12613424 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6320617 [patent_doc_number] => 20100113405 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-05-06 [patent_title] => 'METHYLINDAZOLE MODULATORS OF 5-HT3 RECEPTORS' [patent_app_type] => utility [patent_app_number] => 12/612095 [patent_app_country] => US [patent_app_date] => 2009-11-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10122 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0113/20100113405.pdf [firstpage_image] =>[orig_patent_app_number] => 12612095 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7490566 [patent_doc_number] => 20110237619 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-29 [patent_title] => 'IMIDAZOPYRIDINE DERIVATIVES WHICH INHIBIT THE SECRETION OF GASTRIC ACID' [patent_app_type] => utility [patent_app_number] => 13/132564 [patent_app_country] => US [patent_app_date] => 2009-10-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3711 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0237/20110237619.pdf [firstpage_image] =>[orig_patent_app_number] => 13132564 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9184095 [patent_doc_number] => 08624029 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-01-07 [patent_title] => 'Lipidated imidazoquinoline derivatives' [patent_app_type] => utility [patent_app_number] => 13/125342 [patent_app_country] => US [patent_app_date] => 2009-10-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 18 [patent_no_of_words] => 5913 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13125342 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8152214 [patent_doc_number] => 08168654 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-05-01 [patent_title] => 'Quinuclidine derivatives binding to mucarinic M3 receptors' [patent_app_type] => utility [patent_app_number] => 12/582291 [patent_app_country] => US [patent_app_date] => 2009-10-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24401 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/168/08168654.pdf [firstpage_image] =>[orig_patent_app_number] => 12582291 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8386223 [patent_doc_number] => 08263618 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-09-11 [patent_title] => '8-azabicyclo[3.2.1]octane compounds as MU opioid receptor antagonists' [patent_app_type] => utility [patent_app_number] => 12/578715 [patent_app_country] => US [patent_app_date] => 2009-10-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 3 [patent_no_of_words] => 57379 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12578715 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6064039 [patent_doc_number] => 20110201501 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-08-18 [patent_title] => 'Substituted Pyridines Having a Herbicidal Effect' [patent_app_type] => utility [patent_app_number] => 13/126270 [patent_app_country] => US [patent_app_date] => 2009-10-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 36579 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0201/20110201501.pdf [firstpage_image] =>[orig_patent_app_number] => 13126270 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8808032 [patent_doc_number] => 08445684 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-05-21 [patent_title] => 'Nicotinic acetylcholine receptor ligands and the uses thereof' [patent_app_type] => utility [patent_app_number] => 12/578020 [patent_app_country] => US [patent_app_date] => 2009-10-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 137763 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12578020 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6251738 [patent_doc_number] => 20100028301 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-02-04 [patent_title] => 'IMIDAZO[4,5-c]PYRIDINE COMPOUNDS AND METHODS OF ANTIVIRAL TREATMENT' [patent_app_type] => utility [patent_app_number] => 12/577865 [patent_app_country] => US [patent_app_date] => 2009-10-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 31994 [patent_no_of_claims] => 45 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0028/20100028301.pdf [firstpage_image] =>[orig_patent_app_number] => 12577865 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4639753 [patent_doc_number] => 08017780 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2011-09-13 [patent_title] => 'Therapeutic compounds and uses thereof' [patent_app_type] => utility [patent_app_number] => 12/577042 [patent_app_country] => US [patent_app_date] => 2009-10-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13105 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/017/08017780.pdf [firstpage_image] =>[orig_patent_app_number] => 12577042 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7561823 [patent_doc_number] => 20110275656 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-11-10 [patent_title] => '3H-Imidazo [4, 5-C] Pyridine- 6 -Carboxamides As Anti-Inflammatory Agents' [patent_app_type] => utility [patent_app_number] => 13/119832 [patent_app_country] => US [patent_app_date] => 2009-09-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17377 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0275/20110275656.pdf [firstpage_image] =>[orig_patent_app_number] => 13119832 [rel_patent_id] =>[rel_patent_doc_number] =>)